Correlation Between Synergy Pharmaceuticals and Nextcom

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Synergy Pharmaceuticals and Nextcom at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Synergy Pharmaceuticals and Nextcom into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Synergy Pharmaceuticals and Nextcom, you can compare the effects of market volatilities on Synergy Pharmaceuticals and Nextcom and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Synergy Pharmaceuticals with a short position of Nextcom. Check out your portfolio center. Please also check ongoing floating volatility patterns of Synergy Pharmaceuticals and Nextcom.

Diversification Opportunities for Synergy Pharmaceuticals and Nextcom

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Synergy and Nextcom is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Synergy Pharmaceuticals and Nextcom in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nextcom and Synergy Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Synergy Pharmaceuticals are associated (or correlated) with Nextcom. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nextcom has no effect on the direction of Synergy Pharmaceuticals i.e., Synergy Pharmaceuticals and Nextcom go up and down completely randomly.

Pair Corralation between Synergy Pharmaceuticals and Nextcom

If you would invest  78,700  in Nextcom on January 26, 2024 and sell it today you would earn a total of  800.00  from holding Nextcom or generate 1.02% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.0%
ValuesDaily Returns

Synergy Pharmaceuticals  vs.  Nextcom

 Performance 
       Timeline  
Synergy Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Synergy Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Synergy Pharmaceuticals is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.
Nextcom 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Nextcom are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Nextcom may actually be approaching a critical reversion point that can send shares even higher in May 2024.

Synergy Pharmaceuticals and Nextcom Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Synergy Pharmaceuticals and Nextcom

The main advantage of trading using opposite Synergy Pharmaceuticals and Nextcom positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Synergy Pharmaceuticals position performs unexpectedly, Nextcom can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nextcom will offset losses from the drop in Nextcom's long position.
The idea behind Synergy Pharmaceuticals and Nextcom pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.

Other Complementary Tools

Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance